GoldBamboo.com - Knowledge is strong medicine
  

Tailored Teen Alcohol and Violence Prevention in the ER - Article


  Not Signed In - Sign In / Register







[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Diltiazem ER

Cardizem CD; Cardizem LA; Cardizem SR; Cartia XT; Dilacor XR; Diltia XT; Taztia XT; Tiamate; Tiazac




Clinical Trial: Tailored Teen Alcohol and Violence Prevention in the ER

This study is not yet open for patient recruitment.
Verified by University of Michigan November 2005

Sponsored by: University of Michigan
Information provided by: University of Michigan
ClinicalTrials.gov Identifier: NCT00251212

Purpose

This study is designed to address both alcohol misuse and violence among adolescents ages 14-18 seeking care in an urban emergency department (ED). The study is a randomized controlled trial comparing the effectiveness of a combined Adapted Motivational Interviewing and Skills Training intervention, delivered either by a computer or by a counselor, and an informational handout control condition.
Condition Intervention
Violence
Alcohol Abuse
 Behavior: Adapted Motivational Interviewing & Skills Training

MedlinePlus related topics:  Alcoholism

Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study

Further study details as provided by University of Michigan:
Primary Outcomes: Primary outcome variables include alcohol misuse and violent behaviors.
Secondary Outcomes: Secondary outcome measures include illicit drug use, unintentional injury, delinquency and weapon carriage.
Expected Total Enrollment:  3000

Study start: May 2006;  Expected completion: March 2010
Last follow-up: December 2009;  Data entry closure: March 2010

This study will screen ~3000 adolescents in the ED (ages 14-18) over 30 months. Eligible adolescents will be asked to participate in the longitudinal study, stratified by age and gender and randomized to conditions (n=225/group): Computer Prevention Program, Counselor Prevention Program, or an informational handout control condition. Primary outcomes will be evaluated at 3, 6 and 12-months and include alcohol use/misuse, violent behaviors, illicit drug use, unintentional injury, delinquency, and weapon carriage. The proposed study integrates brief intervention strategies for alcohol misuse and violent behaviors using state-of-the-art technology to tailor the interventions to the specific risk factors of the adolescent. Tailored computerized programs use available technology to replace the need for clinical staff in the ED setting, where there is limited staff time to effect behavior change. This project will provide the critical first step toward the implementation of an integrated prevention program addressing overlapping risk factors that has the potential to be delivered to the millions of adolescents visiting urban Emergency Departments each year.

Eligibility

Ages Eligible for Study:  14 Years   -   18 Years,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • adolescents (ages 14-18) presenting to the ED for a medical injury or illness (except exclusions as noted below)
  • adolescents ability to provide informed assent/consent depending on age
  • access to a parent or guardian to provide informed consent

Exclusion Criteria:

  • adolescents who do not understand English
  • prisoners
  • adolescents classified by medical staff as “Level 1” trauma
  • adolescents deemed unable to provide informed consent
  • adolescents treated in the ED for suicide attempts
  • adolescents triaged to the psychiatric ED

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00251212

Laprisha Berry, MSW, MPH      734-998-7454  Ext. 318 

Michigan
      Hulrey Medical Center, Flint,  Michigan,  48503,  United States

Study chairs or principal investigators

Maureen Walton, PhD, MPH,  Principal Investigator,  University of Michigan   

More Information

Study ID Numbers:  AA-014889-01A1
Last Updated:  December 8, 2005
Record first received:  November 7, 2005
ClinicalTrials.gov Identifier:  NCT00251212
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2006-01-10

Resources



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Diltiazem ER.

December 2, 2008



Page Updated: June 1, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.